Thymosin alpha 1, also called thymalfasin, is an immune-modulating peptide used for selected specialist-directed purposes in some countries. Its approval status and recognised indications vary considerably, so treatment should only be considered after confirming local regulatory approval.
| Generic Name | Thymosin Alpha |
| Strength | 1.6 mg |
| Manufacturer | Gufic Bioscience Limited |
| Packing | 1 vial |
| Prescribed For | Hepatitis B virus (HBV) infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Thymosin alpha 1 is an immune-modulating peptide that influences the development and activity of T lymphocytes. It may also support dendritic cells, natural killer cells and other immune responses. Its clinical role and approved indications differ between countries.